December 18, 2020 First-quarter catalysts for the smaller players Important data releases are on the cards for Rhythm, Wave and Supernus, among others.
November 20, 2019 Acasti plays catch-up to Amarin’s Vascepa Two phase III studies could determine whether the Canadian biotech has an approvable product, but the setting will initially be narrow.
